A new approach for the determination of immunosuppressive drugs using HPLC-MS/MS and Cs+ adducts.
In this study a new principle of measurement in LC-MS/MS (liquid chromatography mass spectrometry) for determination of the immunosuppressive drugs sirolimus, everolimus, tacrolimus, and cyclosporin A has been introduced by using the Cs(+) ion as the product ion in the multiple reaction monitoring mode (MRM). Separation of the immunosuppressive agents was achieved using a phenyl-hexyl-RP column together with a ternary gradient elution profile, consisting of water, methanol and acetonitrile combined with 0.1% v/v formic acid and 0.1 mmol/l Cs+. Quantification was performed using cyclosporin D, ascomycin and 32-desmethoxy-rapamycin as internal standards. The inter-run precision of this new method, expressed as the coefficient of variation, was 2.57% for sirolimus, 2.11% for everolimus, 2.31% for tacrolimus and 2.11% for cyclosporin A.
Kaiser
Patricia
P
Reference Laboratory, Instand e.V., Düsseldorf, Germany. kaiser@instand-ev.de
Akerboom
Theodorus
T
Wood
William Graham
WG
Reinauer
Hans
H
Clin Lab. 2003;49(7-8):329-43
12908733
Clin Chem Lab Med. 2005;43(4):400-2
15899656
Ther Drug Monit. 2001 Dec;23(6):722-4
11802110
Clin Lab. 2006;52(1-2):37-42
16506362
Rapid Commun Mass Spectrom. 1998;12(16):1085-91
9737014
Ther Drug Monit. 1999 Feb;21(1):116-22
10051064
Clin Chem. 2002 Jun;48(6 Pt 1):955-8
12029019
Clin Chim Acta. 2004 Aug 16;346(2):181-90
15256319
Clin Chem. 2005 Oct;51(10):1890-3
16189380
Clin Chem Lab Med. 2002 Jan;40(1):40-5
11916269